ResMed Inc (RSMDF) stock
RSMDFOTCSurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RMD
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Aug 13, 2026Score 21/3011% below fair value
$22.61+0.00 (0.00%)
Close on Oct 19, 2026Market cap $33.17BP/E 22.0Yield 1.04%
ResMed operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
ResMed's operating income for the twelve months ending Jun 30, 2026 was $1.89B, up 11.9% year over year. For fiscal 2026 it was $1.89B, up 11.9% from the year before. Over ten years it grew 16.0% a year on average. The highest annual figure on record is $1.89B in fiscal 2026.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $1.89B | +11.9% |
| FY2025 | Jun 30, 2025 | $1.69B | +27.7% |
| FY2024 | Jun 30, 2024 | $1.32B | +16.6% |
| FY2023 | Jun 30, 2023 | $1.13B | +13.2% |
| FY2022 | Jun 30, 2022 | $1.00B | +10.7% |
| FY2021 | Jun 30, 2021 | $903.68M | +11.6% |
| FY2020 | Jun 30, 2020 | $809.66M | +39.8% |
| FY2019 | Jun 30, 2019 | $579.26M | +6.9% |
| FY2018 | Jun 30, 2018 | $541.83M | +27.3% |
| FY2017 | Jun 30, 2017 | $425.80M | -0.7% |
| FY2016 | Jun 30, 2016 | $428.95M | +4.8% |
| FY2015 | Jun 30, 2015 | $409.24M | +1.0% |
| FY2014 | Jun 30, 2014 | $405.09M | +14.2% |
| FY2013 | Jun 30, 2013 | $354.82M | +20.5% |
| FY2012 | Jun 30, 2012 | $294.41M | +10.3% |
| FY2011 | Jun 30, 2011 | $266.92M | +11.0% |
| FY2010 | Jun 30, 2010 | $240.38M | +26.3% |
| FY2009 | Jun 30, 2009 | $190.31M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026 | Jun 30, 2026 | $448.71M | -1.3% |
| Q3 FY2026 | Mar 31, 2026 | $499.81M | +17.3% |
| Q2 FY2026 | Dec 31, 2025 | $491.66M | +17.8% |
| Q1 FY2026 | Sep 30, 2025 | $446.54M | +15.3% |
| Q4 FY2025 | Jun 30, 2025 | $454.54M | +19.2% |
| Q3 FY2025 | Mar 31, 2025 | $426.27M | +13.8% |
| Q2 FY2025 | Dec 31, 2024 | $417.24M | +51.7% |
| Q1 FY2025 | Sep 30, 2024 | $387.31M | +34.0% |
| Q4 FY2024 | Jun 30, 2024 | $381.22M | +38.5% |
| Q3 FY2024 | Mar 31, 2024 | $374.58M | +24.6% |
| Q2 FY2024 | Dec 31, 2023 | $275.09M | -1.8% |
| Q1 FY2024 | Sep 30, 2023 | $289.00M | +4.8% |
| Q4 FY2023 | Jun 30, 2023 | $275.27M | +7.8% |
| Q3 FY2023 | Mar 31, 2023 | $300.67M | +28.3% |
| Q2 FY2023 | Dec 31, 2022 | $280.19M | +12.7% |
| Q1 FY2023 | Sep 30, 2022 | $275.74M | +5.3% |
| Q4 FY2022 | Jun 30, 2022 | $255.40M | +5.7% |
| Q3 FY2022 | Mar 31, 2022 | $234.27M | +4.9% |
| Q2 FY2022 | Dec 31, 2021 | $248.71M | +12.2% |
| Q1 FY2022 | Sep 30, 2021 | $261.91M | +20.8% |
| Q4 FY2021 | Jun 30, 2021 | $241.64M | +8.2% |
| Q3 FY2021 | Mar 31, 2021 | $223.43M | +2.7% |
| Q2 FY2021 | Dec 31, 2020 | $221.72M | +12.1% |
| Q1 FY2021 | Sep 30, 2020 | $216.90M | +26.8% |
| Q4 FY2020 | Jun 30, 2020 | $223.25M | +84.4% |
| Q3 FY2020 | Mar 31, 2020 | $217.50M | +38.6% |
| Q2 FY2020 | Dec 31, 2019 | $197.81M | +25.9% |
| Q1 FY2020 | Sep 30, 2019 | $171.10M | +18.7% |
| Q4 FY2019 | Jun 30, 2019 | $121.08M | -17.6% |
| Q3 FY2019 | Mar 31, 2019 | $156.98M | +15.1% |
| Q2 FY2019 | Dec 31, 2018 | $157.08M | +7.6% |
| Q1 FY2019 | Sep 30, 2018 | $144.13M | +28.1% |
| Q4 FY2018 | Jun 30, 2018 | $146.88M | +15.3% |
| Q3 FY2018 | Mar 31, 2018 | $136.37M | +27.0% |
| Q2 FY2018 | Dec 31, 2017 | $146.02M | +50.7% |
| Q1 FY2018 | Sep 30, 2017 | $112.56M | +19.6% |
| Q4 FY2017 | Jun 30, 2017 | $127.36M | – |
| Q3 FY2017 | Mar 31, 2017 | $107.40M | – |
| Q2 FY2017 | Dec 31, 2016 | $96.90M | – |
| Q1 FY2017 | Sep 30, 2016 | $94.15M | – |